Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis

Ferrero, 1988, Nucleotide sequence of the gene encoding the monocyte differentiation antigen, CD14, Nucleic Acids Res, 16, 4173, 10.1093/nar/16.9.4173

Wright, 1990, CD14, a receptor for complex of lipopolysaccharide (LPS) and LPS binding protein, Science, 249, 1431, 10.1126/science.1698311

Golenbock, 1995, Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells, J Lab Clin Med, 125, 662

Grunwald, 1992, An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids, J Immunol Methods, 155, 225, 10.1016/0022-1759(92)90289-6

Landmann, 1995, Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock, J Infect Dis, 171, 639, 10.1093/infdis/171.3.639

Endo, 1994, Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF), Res Commun Chem Pathol Pharmacol, 84, 17

Lien, 1998, Elevated levels of serum-soluble CD14 in human immunodefiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events, Blood, 92, 2084, 10.1182/blood.V92.6.2084.418k26_2084_2092

Martin, 1997, Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome, Am J Respir Crit Care Med, 155, 937, 10.1164/ajrccm.155.3.9117029

Nockher, 1994, Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus, Clin Exp Immunol, 96, 15, 10.1111/j.1365-2249.1994.tb06222.x

Lee, 2003, Recombinant bovine CD14 reduces severity of experimental Escherichia coli mastitis in mice, Vet Res, 34, 307, 10.1051/vetres:2003006

Landmann, 1996, Function of soluble CD14 in serum from patients with septic shock, J Infect Dis, 173, 661, 10.1093/infdis/173.3.661

1992, Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit Care Med, 20, 864, 10.1097/00003246-199206000-00025

Assicot, 1993, High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, 515, 10.1016/0140-6736(93)90277-N

Bufler, 1995, Soluble lipopolysaccharide receptor (CD14) released via two different mechanisms from human monocytes and CD14 transfectants, Eur J Immunol, 25, 604, 10.1002/eji.1830250244

Bazil, 1991, Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes, J Immunol, 147, 1567, 10.4049/jimmunol.147.5.1567

Dellinger, 2004, Surviving sepsis campaign guidelines for management of severe sepsis and septic shock, Intensive Care Med, 30, 536, 10.1007/s00134-004-2210-z

Oliver, 2000, Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6, Crit Care Med, 28, 2793, 10.1097/00003246-200008000-00019

Holzheimer, 2000, Immunological surrogate parameters in a prognostic model for multi-organ failure and death, Eur J Med Res, 5, 283